Kennedy Capital Management’s MGC Diagnostics Corporation MGCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-229,782
Closed -$2.53M 804
2017
Q4
$2.53M Buy
+229,782
New +$2.21M 0.05% 591

Kennedy Capital Management's MGCD Position: Q1 2018 in Review

Kennedy Capital Management sold out of MGC Diagnostics Corporation (MGCD) in Q1 2018, closing a stake of 229,782 shares — an estimated $2.53M sold.

Kennedy Capital Management first reported a position in MGCD in Q4 2017 and held it in 1 quarter. The position peaked at $2.53M in Q4 2017. 0 funds tracked by Wall St. Rank hold MGCD as of Q1 2018.

  • Kennedy Capital Management reported no remaining MGC Diagnostics Corporation position as of Q1 2018 after selling out during the quarter.
  • Kennedy Capital Management sold 229,782 MGC Diagnostics Corporation shares in Q1 2018, an estimated $2.53M.
  • Kennedy Capital Management first reported a position in MGC Diagnostics Corporation in Q4 2017 and held it in 1 quarter.
  • Kennedy Capital Management's MGC Diagnostics Corporation position peaked at $2.53M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2018.

Based on Kennedy Capital Management's 13F filing for Q1 2018, filed 14 May 2018.